Company: VREOF
Filing Date: 2025-03-21
Form Type: DEFM14C
Source: 0001140361-25-009815
Chunk: 88

Company: Vireo Growth Inc.
Filing Date: 2025-03-21
Form: DEFM14C
Chunk 88
---
 Arches) conduct their businesses. The Company and Wholesome Merger Sub also made a number of representations and warranties to Wholesome, including the following:

| • | the organization, good standing and qualification of each of the Company and Wholesome Merger Sub; |

| • | the Company’s and Wholesome Merger Sub’s respective corporate power and authority to execute and deliver the Wholesome Merger Agreement, perform its obligations thereunder and under the documents and agreements contemplated by the Wholesome Merger Agreement, and to consummate the Wholesome Transactions, and the enforceability and due execution and delivery of the Wholesome Merger Agreement and the documents and agreements contemplated by the Wholesome Merger Agreement; |

| • | the absence of conflicts with governing documents, applicable laws and contracts; |

| • | the operations of Wholesome Merger Sub; |

47

TABLE OF CONTENTS

| • | brokers’ and finders’ fees and other expenses payable by the Company or Wholesome Merger Sub; |

| • | the solvency of the Company and Wholesome Merger Sub; |

| • | the absence of certain suits, claims, actions, proceedings, arbitrations, mediations or investigations; |

| • | the capitalization of the Company and certain matters with respect to the Subordinate Voting Shares; |

| • | the financial statements of the Company; |

| • | the absence of certain undisclosed material liabilities; |

| • | the compliance with applicable laws; |

| • | certain U.S. and Canadian securities laws matters; and |

| • | certain U.S. tax matters. |

Some of the representations and warranties made by the Company and Wholesome Merger Sub in the Wholesome Merger Agreement are qualified by a materiality or Parent Material Adverse Effect standard. A “Parent Material Adverse Effect” means any effect, event, development, occurrence, fact, condition or change that has a material adverse effect, individually or in the aggregate, (a) on the business, results of operations, condition (financial or otherwise), liabilities or assets of the Company or its affiliates, taken as a whole, or (b) on the ability of the Company or Wholesome Merger Sub to perform its obligations under the Wholesome Merger Agreement or to consummate the Wholesome Merger, or on the consummation of (whether by prevention or material delay) the Wholesome Merger and the other transactions